Edgewise Therapeutics, Inc. EWTX
Set alert
37.87 USD -0.24 -0.63%
As of Nov 3, 3:11 PM ET
36.70 Day range 40.41
16.70 52-week range 48.51
- YTD
- +52.57%
- 1 year
- +110.73%
- Open
- 38.73
- Prev close
- 38.11
- Mkt cap
- 4.11B
- Vol
- 1.16M
- Avg vol
- 1.46M
- EPS
- -1.86
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 36.70
- High
- 40.41
- Forward P/E
- -20.39
- Beta
- 0.40
- Short ratio
- 6.61
- Inst. own
- 112.25%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 41.34
- 200-d avg
- 36.28
- 1y target
- 54.00
3M chart
Events in this range
- Aug 6, 2026Earnings: -0.53; estimate -0.46769; surprise -13.32%
- Aug 11, 2026Rating: Goldman Sachs · Neutral → Neutral
- Aug 20, 2026Rating: JP Morgan · Overweight → Overweight
- Sep 21, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Oct 16, 2026Rating: William Blair · — → Outperform
Signals (22)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 29, 2026 | 5 days ago |
| SMA: Bullish | Oct 28, 2026 | 6 days ago |
| MACD: Buy Signal | Oct 20, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 16, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 15, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| SMA: Bullish | Sep 4, 2026 | 2 months ago |
| SMA: Bullish | Sep 4, 2026 | 2 months ago |
| SMA: Bearish | Sep 2, 2026 | 2 months ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 21, 2026 | 2 months ago |
Newest 20 of 22.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 54.00 +42.6% upside
Now 37.87
- Target (low)
- 36.00
- Target (mean)
- 54.00
- Target (high)
- 66.00
Ratings (0m) 13 12 buy · 1 hold · 0 sell
- Strong buy3
- Buy9
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 13
- 1 month ago 13
- 2 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.51 | -0.64 – 11.45 | -0.39 | +744.4% | 0 | 0.0% | 11 |
| Next quarter | -0.46845 | -0.78 – -0.13 | -0.47 | +0.3% | 0 | 0.0% | 12 |
| Current year | 2.27 | -2.42 – 11.22 | -1.63 | +239.6% | 0 | 0.0% | 11 |
| Next year | -1.87 | -3.44 – -0.47 | 2.27 | -182.2% | 31.36M | 0.0% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 16, 2026 | William Blair | Initiated | — | Outperform |
| Sep 21, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 20, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 11, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Jul 20, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 9, 2026 | Oppenheimer | Initiated | — | Outperform |
| Jul 6, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jun 17, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jun 17, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Jun 16, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 2, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 2, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jun 2, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Mar 17, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Mar 17, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Feb 27, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Nov 14, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 7, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 7, 2025 | Wedbush | Maintained | Outperform | Outperform |
| Sep 25, 2025 | Goldman Sachs | Initiated | — | Neutral |
| Aug 19, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 8, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Jun 30, 2025 | HC Wainwright & Co. | Initiated | — | Buy |
| Jun 5, 2025 | RBC Capital | Reiterated | Outperform | Outperform |
| May 16, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| May 9, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Apr 21, 2025 | Wedbush | Maintained | Outperform | Outperform |
| Apr 3, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Apr 3, 2025 | Scotiabank | Downgrade | Sector Outperform | Sector Perform |
| Apr 2, 2025 | Piper Sandler | Maintained | Overweight | Overweight |